Across TCGA pan-cancer cohorts, CTSLP4 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated CTSLP4 data layer.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher CTSLP4 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CTSLP4 expression acts as an unfavorable survival marker, although some lineages such as THYM and BLCA show a favorable association.
COAD, DLBC, and UCEC are the cancer types where CTSLP4 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.